The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

MEN with aggressive prostate cancer could benefit from a new drug combination that slows cancer growth, scientists say.

Thousands of men with incurable prostate cancer could live longer thanks to a breakthrough study that found combining two ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

Former President Joe Biden has begun radiation therapy, in addition to hormone therapy, to treat aggressive prostate cancer, ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...